These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The natural history of renal function following orthotopic heart transplant. Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562 [TBL] [Abstract][Full Text] [Related]
9. Results of "immunoconversion" from cyclosporine to azathioprine in heart transplant recipients with progressive nephrotoxicity. Hunt SA; Stinson EB; Oyer PE; Billingham ME; Gamberg P; Miller J; Schroeder JS; Baldwin JC; Shumway NE Transplant Proc; 1987 Feb; 19(1 Pt 3):2522-4. PubMed ID: 3274554 [No Abstract] [Full Text] [Related]
10. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients. Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743 [TBL] [Abstract][Full Text] [Related]
11. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients. Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904 [No Abstract] [Full Text] [Related]
13. Effect of cyclosporine on the rate of renal function recovery after renal transplantation. Dumler F Henry Ford Hosp Med J; 1989; 37(1):24-7. PubMed ID: 2670841 [TBL] [Abstract][Full Text] [Related]
14. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results. Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555 [TBL] [Abstract][Full Text] [Related]
15. Five years' follow-up of renal glomerular and tubular functions in heart transplant recipients. Hartmann A; Andereassen AK; Holdaas H; Simonsen S; Geiran O; Berg KJ J Heart Lung Transplant; 1996 Oct; 15(10):972-9. PubMed ID: 8913913 [TBL] [Abstract][Full Text] [Related]
16. Cyclosporine-associated chronic nephropathy. Myers BD; Ross J; Newton L; Luetscher J; Perlroth M N Engl J Med; 1984 Sep; 311(11):699-705. PubMed ID: 6382005 [TBL] [Abstract][Full Text] [Related]
17. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection. Sandborn WJ; Hay JE; Porayko MK; Gores GJ; Steers JL; Krom RA; Wiesner RH Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267 [TBL] [Abstract][Full Text] [Related]
18. Stability of long-term renal function in heart transplant patients treated with induction therapy and low-dose cyclosporine. Gonwa TA; Mai ML; Pilcher J; Johnson C; Pierson S; Capehart JE; Alivizatos PA J Heart Lung Transplant; 1992; 11(5):926-8. PubMed ID: 1420240 [TBL] [Abstract][Full Text] [Related]
19. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation. Olivari MT; Jessen ME; Baldwin BJ; Horn VP; Yancy CW; Ring WS; Rosenblatt RL J Heart Lung Transplant; 1995; 14(1 Pt 1):127-35. PubMed ID: 7727461 [TBL] [Abstract][Full Text] [Related]
20. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy. Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]